Established in 2011, HEOR is a leading independent market access consultancy with a reputation for high-quality, innovative market access strategies, evidence generation and value communications. 

We are a team of over 90 consulting and research professionals based in the UK and Germany and our expertise spans market access strategy, health economics, health technology assessments, pricing and reimbursement, data science and analytics, systematic literature reviews, evidence generation, medical writing, stakeholder engagement and value communication. 

We have a global presence and work across the UK, Europe, US, Canada, Asia-Pacific and the Middle East to provide a fully integrated market access service across the product life-cycle.

HEOR Ltd acts as a trusted partner to the world’s major pharmaceutical and biopharmaceutical companies. Our clients value our flexibility, integrity to scientific principles and best practice and our ethos of true partnership, where our track record speaks to deep and continuing client collaborations, across all disease areas and service offerings. 




Biotechnology

Health Care

Health Data

Life Sciences

Pharmaceutical

HEOR

Phil McEwan

Eamus Halpin

Daniel Finnegan

Andrew King

Sorcha Bangham Chartered Fcipd

Jeff Anderson

Carissa Dickerson

Hannah Lorquet

HEOR

Org chart

Teams

Similar companies